Share Prices & Company Research

Stockbroking

Ergomed

Current Price 366.96p Bid 366.00p Ask 382.00p Change 0.00%
Last Updated: 17/11/2019 04:36. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Ergomed plc provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing, profitable services offering encompasses a complete suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand, in addition to a full range of high quality contract research and trial management services (CRO). Leveraging its CRO expertise, Ergomed also has a drug development portfolio of co-development partnerships and wholly-owned programmes.

Financial Highlights Year Ended 31/12/2018

Turnover
£54.11m
Operating Profit
£-10.45m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-18.70

Key Personnel

Richard Timothy Barfield
Chief Financial Officer
Dr Jan Petracek
Chief Operating Officer
Dr Miroslav Reljanovic
Executive Chairman
Michael William Spiteri
Non-Executive Director
Peter Lutz George
Non-Executive Director

Stock Details

EPIC
ERGO
ISIN
GB00BN7ZCY67
Shares in Issue
47,239,206
Market cap
£176.68m
Sector

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
374.00p
Bid Price
366.00p
Ask Price
382.00p
Volume
42413
Change Today
0.00p
% Change Today
0.00%
Open
377.50p
Previous Close
374.00p
Intraday High
378.00p
Intraday Low
366.96p
52 Week High
388.00p
52 Week Low
147.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Ergomed Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
1.3
1.1
Intangible Assets & Goodwill
17.4
35.5
Investments & Other Non-Current Assets
2.7
2.4
Total Non-Current Assets
21.4
38.9
Inventory
0.0
0.0
Trade & Receivables
16.4
19.3
Cash & Receivables
5.2
3.2
Other Current Assets & Assets Held for Resale
3.9
0.5
Total Assets
46.9
61.9

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
17.2
13.9
Long Term Liabilities
1.3
13.2
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
18.5
27.1

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
28.4
34.8

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
0.5
0.4
Minority Interests
0.0
0.0
Retained Earnings
-11.9
-0.7
Share Premium Account
24.5
20.6
Other Equity
15.3
14.4
Total Equity
28.4
34.8

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
1.0
0.0
Cashflow Before Financing
-1.7
-3.9
Increase / Decrease in Cash
2.1
-1.2

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
54.1
47.6
Cost of Sales
34.9
33.0
Gross Profit
19.3
14.6
Operating Profit
-10.5
-3.9
Pre-Tax Profit
-10.8
-4.5
Profit / Loss for the Year
-9.0
-4.5
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.